arrow
返回

StrEAMM-Thioether: Efficient Structure Prediction for Thioether-Linked Cyclic Peptides

delete2026-02-05
delete0
PRE
AI
M
Minh Ngoc Ho
J
Jiaxu Miao
Y
Yi Shan
C
C. Li
H
Hiroaki Suga
J
James Baleja
Y
Yu‐Shan Lin *
DOI:10.1021/acs.jpcb.5c06368delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
Cyclic peptides have gained interest as potential therapeutics due to their ability to target specific protein–protein interactions and be membrane-permeable. Understanding the sequence–structure relationship of cyclic peptides would greatly benefit their rational design. However, cyclic peptides tend to adopt multiple conformations in solution, and it remains challenging to use experimental techniques such as solution NMR to delineate their structural ensembles: i.e., the different structures a cyclic peptide adopts and the associated populations. Alternatively, molecular dynamics (MD) simulations can be used to provide such information. However, MD simulations are computationally expensive and not applicable for large-scale screening. Our group has developed the StrEAMM (Structural Ensembles Achieved by Molecular Dynamics and Machine Learning) computational platform and applied it to predict structural ensembles of head-to-tail cyclized pentapeptides and hexapeptides. However, head-to-tail cyclized peptides can be challenging to synthesize due to low yield and complicated reaction workup and product isolation. Furthermore, head-to-tail cyclized peptides are not compatible with screening techniques like mRNA display. Here, we expand the StrEAMM method to thioether-linked cyclic peptides, a popular scaffold in mRNA display. The trained graph neural network models are able to provide fast and simulation-quality structural ensembles for thioether-linked cyclic peptides. Using these models, we identify four thioether-linked cyclic pentapeptides that are predicted to be the best-structured and subsequently experimentally synthesize and characterize them by solution NMR. We observe general agreement between the predicted structures and the NMR results. Ultimately, we envision that StrEAMM-thioether models can work synergistically with the current mRNA platform to streamline the resource-intensive process of drug discovery and design of cyclic peptides.
Keyword:
Chemical structure
Conformation
Monomers
Peptides and proteins
Simulated annealing

期刊

T
The Journal of Physical Chemistry B
IF:
2.9
论文数:
767
被引数:
2

机构

T
the university of tokyo
学者数:
5.0K
论文数: 2.3K
被引数: 1
T
tufts university
学者数:
1.7W
论文数: 1.5W
被引数: 24
引用论文

引用论文

Conformation and Dynamics of Human Urotensin II and Urotensin Related Peptide in Aqueous Solution
err2017-01-23
err13
errOAAI
errHaensele, Elke; Mele, Nawel; Miljak, Marija; Read, Christopher M.; Whitley, David C.; Banting, Lee; Delepee, Carla; Santos, Jana Sopkova-de Oliveira; Lepailleur, Alban; Bureau, Ronan; Essex, Jonathan W.; Clark, Timothy
err分享
err收藏
Rapid Discovery of Potent and Selective Glycosidase-Inhibiting De Novo Peptides
err2017-03-01
err44
errOAAI
errJongkees, Seino A. K.; Caner, Sami; Tysoe, Christina; Brayer, Gary D.; Withers, Stephen G.; Suga, Hiroaki
err分享
err收藏
Peptide Head‐to‐Tail Cyclization: A “Molecular Claw” Approach
err2021-05-04
err0
PREAI
errSayuri Yamagami; Yohei Okada; Yoshikazu Kitano; Kazuhiro Chiba
err分享
err收藏
Predicting the effects of mutations on protein solubility using graph convolution network and protein language model representation
err2023-11-07
err5
PREAI
errWang, Jing; Chen, Sheng; Yuan, Qianmu; Chen, Jianwen; Li, Danping; Wang, Lei; Yang, Yuedong
err分享
err收藏
A Macrocyclic Peptide that Serves as a Cocrystallization Ligand and Inhibits the Function of a MATE Family Transporter
err2013-08-30
err47
errOAAI
errHipolito, Christopher J.; Tanaka, Yoshiki; Katoh, Takayuki; Nureki, Osamu; Suga, Hiroaki
err分享
err收藏
Predicting the Thermodynamics and Kinetics of Helix Formation in a Cyclic Peptide Model
err2013-10-11
err32
PREAI
errDamas, Joao M.; Filipe, Luis C. S.; Campos, Sara R. R.; Lousa, Diana; Victor, Bruno L.; Baptista, Antonio M.; Soares, Claudio M.
err分享
err收藏
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors
err2021-10-27
err88
PREAI
errTucker, Thomas J.; Embrey, Mark W.; Alleyne, Candice; Amin, Rupesh P.; Bass, Alan; Bhatt, Bhavana; Bianchi, Elisabetta; Branca, Danila; Bueters, Tjerk; Buist, Nicole; Ha, Sookhee N.; Hafey, Mike; He, Huaibing; Higgins, John; Johns, Douglas G.; Kerekes, Angela D.; Koeplinger, Kenneth A.; Kuethe, Jeffrey T.; Li, Nianyu; Murphy, BethAnn; Orth, Peter; Salowe, Scott; Shahripour, Aurash; Tracy, Rodger; Wang, Weixun; Wu, Chengwei; Xiong, Yusheng; Zokian, Hratch J.; Wood, Harold B.; Walji, Abbas
err分享
err收藏
p53 mutations in cancer
err2013-01-01
err1.5K
PREAI
errMuller, Patricia A. J.; Vousden, Karen H.
err分享
err收藏
De novo macrocyclic peptides that specifically modulate Lys48-linked ubiquitin chains
err2019-06-10
err72
errOAAI
errNawatha, Mickal; Rogers, Joseph M.; Bonn, Steven M.; Livneh, Ido; Lemma, Betsegaw; Mali, Sachitanand M.; Vamisetti, Ganga B.; Sun, Hao; Bercovich, Beatrice; Huang, Yichao; Ciechanover, Aaron; Fushman, David; Suga, Hiroaki; Brik, Ashraf
err分享
err收藏
学者 查看更多内容